De. Hatzigeorgiou et al., IL-6 DOWN-MODULATES THE CYTOKINE-ENHANCED ANTILEISHMANIAL ACTIVITY INHUMAN MACROPHAGES, The Journal of immunology, 151(7), 1993, pp. 3682-3692
IL-6 is a cytokine synthesized by T cells and macrophages (Mphi). It h
as pleiotropic effects on diverse cell types and is recognized for its
''pro-inflammatory'' properties. In mice, IL-4, IL-5, IL-6, and IL-10
are produced by Th-2 cells. Because IL-10 suppresses Th-1 clones, and
IL-4 broadly deactivates Mphi, experiments were carried out to invest
igate the in vitro effects of recombinant human IL-6 on cytokine activ
ation of human Mphi. Pretreatment with IL-6 induced a dose- and time-d
ependent suppression of IFN-gamma (1000 U/mL) and TNF-alpha (25 ng/mL)
activation of Mphi for the killing of L. amazonensis. At doses greate
r than 0.1 to 100 ng/mL, IL-6 inhibited IFN-gamma and TNF-alpha activa
tion by 21 to 93% and 36 to 82%, respectively. IL-6 alone had no effec
t on Mphi viability and intracellular L. amazonensis growth. Blockade
of Mphi activation was greatest when IL-6 was added 24 or 48 h before
infection and treatment with IFN-gamma or TNF-alpha. Furthermore, mAb
against IL-6 abrogated the inhibitory activity of IL-6. Similarly IL-6
pretreatment suppressed Mphi activation for antileishmanial capacity
by IL-3, granulocyte-monocyte-CSF (GM-CSF) and IL-1 beta. Because cyto
kine induction of antileishmanial activity is associated with enhancem
ent of oxidative capacity, the effect of IL-6 on this mechanism was ev
aluated. Pretreatment with IL-6 down-modulated TNF-alpha (25 ng/mL) en
hancement of Mphi oxidative capacity in a dose- and time-dependent man
ner. A similar depression of oxidative capacity was observed for GM-CS
F and IL-3 but not for IFN-gamma. Furthermore, N(G)-monomethyl-L-argin
ine (a nitric oxide synthase inhibitor) had no effect on IFN-gamma and
TNF-alpha activation of antileishmanial activity and nitrites/nitrate
s were not reliably assayed from Mphi culture supernatants. These find
ings suggest that IL-6 down-modulates cytokine activation of Mphi anti
leishmanial capacity by inhibiting oxygen-dependent and undefined oxyg
en-independent mechanisms.